drugset / Trial / NCT02356679

Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients

NCT02356679

Phase 4 Completed 230 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is evaluate the Efficacy and Safety of EUPASIDIN-S Tab. in Gastritis Patients.

Timeline

Start
2014-08
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Eupasidin-s Unknown 60 mg
Comparator Stillen Unknown 60 mg

Indications